PHILADELPHIA, PA / ACCESS Newswire / May 5, 2025 / The law firm of Kaskela Law LLC announces that it is investigating Solid Biosciences Inc. (NASDAQ:SLDB) on behalf of the company's shareholders.
Click here to receive additional information: https://kaskelalaw.com/case/solid-biosciences/
Since February 2025, shares of Solid Biosciences' common stock have declined in value from a trading price of over $6.00 per share to a current trading price of less than $4.50 per share, a decline of over 25% in value.
The investigation seeks to determine whether Solid Biosciences and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions.
Solid Biosciences shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 - 0750, or by clicking on the following link (or by copying and pasting the link into your browser):
https://kaskelalaw.com/case/solid-biosciences/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC
View the original
press release on ACCESS Newswire
